{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:10:50Z","timestamp":1794499850319,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009553","name":"Czech Health Research Council","doi-asserted-by":"crossref","award":["NU20-05-00320"],"award-info":[{"award-number":["NU20-05-00320"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["00064203"],"award-info":[{"award-number":["00064203"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["19-0704S"],"award-info":[{"award-number":["19-0704S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Chronic Recurrent Multifocal Osteomyelitis (CRMO) is an autoinflammatory bone disorder with predominantly paediatric onset. Children present with multifocal osteolytic lesions accompanied by bone pain and soft tissue swelling. Patients often exhibit extraosseous co-morbidities such as psoriasis, inflammatory bowel disease, and arthritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Comparison of children with two different phenotypes of CRMO defined by presence or absence of extraosseous co-morbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Children diagnosed with CRMO at the Motol University Hospital between 2010 and 2020 were retrospectively reviewed, and according to the absence or presence of extraosseous manifestations divided into two cohorts \u2013 bone limited CRMO and complex CRMO. The two groups were compared in terms of demographic data, age at disease onset, number and site of bone lesions, laboratory biomarker values, and need of escalation to a second-line therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty-seven children (30 female, 7 male) with confirmed CRMO were included in the analysis. The mean age at disease onset was 10 years. All but 3 patients presented with multifocal disease. Twenty-three children (62%) had at least one extraosseous manifestation (13 sacroiliitis, 8 inflammatory bowel disease, 6 skin disease [acne, pustulosis, or psoriasis], 7 arthritis). Complex CRMO was associated with a significantly higher ESR rate (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.0064) and CRP level (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.018). The groups did not differ in number of foci or in age at disease onset. Bone lesion distribution differed between the two groups with significantly more frequent involvement of clavicle (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.011) and pelvis (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.038) in patients with complex CRMO. Children with complex CRMO more often needed escalation of therapy to DMARDs and biologic agents.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our data suggest that CRMO affecting solely the skeleton has milder course compared to complex CRMO with extraskeletal features. Further studies are needed to explore the clinical as well as the patient reported outcomes and promote individually tailored therapeutic strategies in both CRMO phenotypes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-022-00772-w","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:14:47Z","timestamp":1669900487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Two phenotypes of chronic recurrent multifocal osteomyelitis with different patterns of bone involvement"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6529-2740","authenticated-orcid":false,"given":"Dita","family":"Cebecauerov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Malcov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Koukolsk\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Kv\u00ed\u010dalov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Sou\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luk\u00e1\u0161","family":"Wagenknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Bronsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zden\u011bk","family":"\u0160umn\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kyn\u010dl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Cebecauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"772_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0022-3476(78)80501-0","volume":"93","author":"B Bjorksten","year":"1978","unstructured":"Bjorksten B, Gustavson KH, Eriksson B, Lindholm A, Nordstrom S. Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr. 1978;93:227\u201331.","journal-title":"J Pediatr"},{"key":"772_CR2","first-page":"329","volume":"15","author":"A Giedion","year":"1972","unstructured":"Giedion A. Subacute and chronic \"symmetrical\" osteomyeliti. Ann Radiol (Paris). 1972;15:329\u201342.","journal-title":"Ann Radiol (Paris)"},{"key":"772_CR3","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/j.1651-2227.2011.02205.x","volume":"100","author":"AF Jansson","year":"2011","unstructured":"Jansson AF, Grote V, Group, E.S. Nonbacterial osteitis in children: data of a German Incidence Surveillance Study. Acta Paediatr. 2011;100:1150\u20137.","journal-title":"Acta Paediatr"},{"key":"772_CR4","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/rheumatology\/keaa303","volume":"59","author":"S Andronikou","year":"2020","unstructured":"Andronikou S, et al. Whole-body MRI in the diagnosis of paediatric CNO\/CRMO. Rheumatology (Oxford). 2020;59:2671\u201380.","journal-title":"Rheumatology (Oxford)"},{"key":"772_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.pcl.2018.04.003","volume":"65","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Ferguson PJ. Chronic Nonbacterial Osteomyelitis and Chronic Recurrent Multifocal Osteomyelitis in Children. Pediatr Clin North Am. 2018;65:783\u2013800.","journal-title":"Pediatr Clin North Am"},{"key":"772_CR6","doi-asserted-by":"publisher","first-page":"e1190","DOI":"10.1542\/peds.2011-3788","volume":"130","author":"A Borzutzky","year":"2012","unstructured":"Borzutzky A, et al. Pediatric chronic nonbacterial osteomyelitis. Pediatrics. 2012;130:e1190\u20137.","journal-title":"Pediatrics"},{"key":"772_CR7","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/art.39013","volume":"67","author":"J Wipff","year":"2015","unstructured":"Wipff J, et al. A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol. 2015;67:1128\u201337.","journal-title":"Arthritis Rheumatol"},{"key":"772_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12969-021-00530-4","volume":"19","author":"D O'Leary","year":"2021","unstructured":"O'Leary D, Wilson AG, MacDermott EJ, Lowry C, Killeen OG. Variability in phenotype and response to treatment in chronic nonbacterial osteomyelitis; the Irish experience of a national cohort. Pediatr Rheumatol Online J. 2021;19:45.","journal-title":"Pediatr Rheumatol Online J"},{"key":"772_CR9","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/rheumatology\/key058","volume":"57","author":"H Girschick","year":"2018","unstructured":"Girschick H, et al. The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry. Rheumatology (Oxford). 2018;57:1203\u201311.","journal-title":"Rheumatology (Oxford)"},{"key":"772_CR10","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/acr.23462","volume":"70","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, et al. Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and\/or With Active Spinal Lesions. Arthritis Care Res (Hoboken). 2018;70:1228\u201337.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"772_CR11","doi-asserted-by":"publisher","first-page":"e0169687","DOI":"10.1371\/journal.pone.0169687","volume":"12","author":"AJ Cox","year":"2017","unstructured":"Cox AJ, et al. Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO). PLoS One. 2017;12:e0169687.","journal-title":"PLoS One"},{"key":"772_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12969-020-00447-4","volume":"18","author":"AP d'Adamo","year":"2020","unstructured":"d'Adamo AP, et al. High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO). Pediatr Rheumatol Online J. 2020;18:55.","journal-title":"Pediatr Rheumatol Online J"},{"key":"772_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/jmg.2005.030759","volume":"42","author":"PJ Ferguson","year":"2005","unstructured":"Ferguson PJ, et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet. 2005;42:551\u20137.","journal-title":"J Med Genet"},{"key":"772_CR14","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","volume":"360","author":"I Aksentijevich","year":"2009","unstructured":"Aksentijevich I, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med. 2009;360:2426\u201337.","journal-title":"N Engl J Med"},{"key":"772_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/1529-0131(200001)43:1<109::AID-ANR14>3.0.CO;2-3","volume":"43","author":"O Vittecoq","year":"2000","unstructured":"Vittecoq O, et al. Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis Rheum. 2000;43:109\u201319.","journal-title":"Arthritis Rheum"},{"key":"772_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/rheumatology\/kel190","volume":"46","author":"A Jansson","year":"2007","unstructured":"Jansson A, et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford). 2007;46:154\u201360.","journal-title":"Rheumatology (Oxford)"},{"key":"772_CR17","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/ar2992","volume":"12","author":"C Beck","year":"2010","unstructured":"Beck C, et al. Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther. 2010;12:R74.","journal-title":"Arthritis Res Ther"},{"key":"772_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00296-018-4151-9","volume":"39","author":"MM Kostik","year":"2019","unstructured":"Kostik MM, Kopchak OL, Chikova IA, Isupova EA, Mushkin AY. Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis. Rheumatol Int. 2019;39:89\u201396.","journal-title":"Rheumatol Int"},{"key":"772_CR19","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3899\/jrheum.161255","volume":"44","author":"A Schnabel","year":"2017","unstructured":"Schnabel A, Range U, Hahn G, Berner R, Hedrich CM. Treatment Response and Longterm Outcomes in Children with Chronic Nonbacterial Osteomyelitis. J Rheumatol. 2017;44:1058\u201365.","journal-title":"J Rheumatol"},{"key":"772_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MPG.0000000000003225","volume":"73","author":"MJ Dushnicky","year":"2021","unstructured":"Dushnicky MJ, et al. Pediatric Patients with a Dual Diagnosis of Inflammatory Bowel Disease and Chronic Recurrent Multifocal Osteomyelitis. J Pediatr Gastroenterol Nutr. 2021;73:626\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"772_CR21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.24953\/turkjped.2019.03.010","volume":"61","author":"E Sag","year":"2019","unstructured":"Sag E, et al. Chronic recurrent multifocal osteomyelitis in children: a single center experience over five years. Turk J Pediatr. 2019;61:386\u201391.","journal-title":"Turk J Pediatr"},{"key":"772_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12969-016-0109-1","volume":"14","author":"MR Roderick","year":"2016","unstructured":"Roderick MR, Shah R, Rogers V, Finn A, Ramanan AV. Chronic recurrent multifocal osteomyelitis (CRMO) - advancing the diagnosis. Pediatr Rheumatol Online J. 2016;14:47.","journal-title":"Pediatr Rheumatol Online J"},{"key":"772_CR23","first-page":"187","volume":"54","author":"AM Chamot","year":"1987","unstructured":"Chamot AM, et al. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic. 1987;54:187\u201396.","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"772_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00002281-199507000-00001","volume":"7","author":"MA Khan","year":"1995","unstructured":"Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol. 1995;7:263\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"772_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-020-0454-9","volume":"16","author":"E Gracey","year":"2020","unstructured":"Gracey E, et al. Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis. Nat Rev Rheumatol. 2020;16:415\u201333.","journal-title":"Nat Rev Rheumatol"},{"key":"772_CR26","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/j.berh.2020.101494","volume":"33","author":"B Myers","year":"2019","unstructured":"Myers B, et al. The gut microbiome in psoriasis and psoriatic arthritis. Best Pract Res Clin Rheumatol. 2019;33:101494.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"772_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12969-016-0114-4","volume":"14","author":"A Verwoerd","year":"2016","unstructured":"Verwoerd A, Ter Haar NM, de Roock S, Vastert SJ, Bogaert D. The human microbiome and juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14:55.","journal-title":"Pediatr Rheumatol Online J"},{"key":"772_CR28","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.3390\/nu13114005","volume":"13","author":"E Cantarelli","year":"2021","unstructured":"Cantarelli E, Baccelli F, Simonini G, Alvisi P. Chronic recurrent multifocal osteomyelitis associated with crohn disease: a potential role of exclusion diet? comment on starz et al. The modification of the gut microbiota via selected specific diets in patients with crohn's disease. Nutrients 2021, 13, 2125. Nutrients. 2021;13:4005.","journal-title":"Nutrients"},{"key":"772_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11926-017-0654-8","volume":"19","author":"N Akkoc","year":"2017","unstructured":"Akkoc N, Yarkan H, Kenar G, Khan MA. Ankylosing Spondylitis: HLA-B*27-Positive Versus HLA-B*27-Negative Disease. Curr Rheumatol Rep. 2017;19:26.","journal-title":"Curr Rheumatol Rep"},{"key":"772_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.berh.2006.03.010","volume":"20","author":"M Rudwaleit","year":"2006","unstructured":"Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol. 2006;20:451\u201371.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"772_CR31","first-page":"499","volume":"7","author":"H Mielants","year":"1989","unstructured":"Mielants H, Veys EM, Cuvelier C, De Vos M. Subclinical involvement of the gut in undifferentiated spondylarthropathies. Clin Exp Rheumatol. 1989;7:499\u2013504.","journal-title":"Clin Exp Rheumatol"},{"key":"772_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrrheum.2015.133","volume":"12","author":"MA Brown","year":"2016","unstructured":"Brown MA, Kenna T, Wordsworth BP. Genetics of ankylosing spondylitis--insights into pathogenesis. Nat Rev Rheumatol. 2016;12:81\u201391.","journal-title":"Nat Rev Rheumatol"},{"key":"772_CR33","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3899\/jrheum.140472","volume":"42","author":"D Barthel","year":"2015","unstructured":"Barthel D, et al. Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics. J Rheumatol. 2015;42:2160\u20135.","journal-title":"J Rheumatol"},{"key":"772_CR34","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/apt.13352","volume":"42","author":"D Pugliese","year":"2015","unstructured":"Pugliese D, et al. Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study. Aliment Pharmacol Ther. 2015;42:880\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"772_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40272-021-00440-8","volume":"23","author":"N Rosenwasser","year":"2021","unstructured":"Rosenwasser N, Lee D, Sidbury R, Zhao Y. Paradoxical Psoriasis in Children Receiving Anti-TNFalpha Treatment for Inflammatory\/autoimmune Disease. Paediatr Drugs. 2021;23:131\u201341.","journal-title":"Paediatr Drugs"},{"key":"772_CR36","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377:2138\u201349.","journal-title":"Lancet"},{"key":"772_CR37","volume-title":"Juvenile Idiopathic Arthritis","author":"A Thatayatikom","year":"2022","unstructured":"Thatayatikom A, Modica R, De Leucio A. Juvenile Idiopathic Arthritis. Treasure Island: StatPearls; 2022."}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00772-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-022-00772-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00772-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:23:42Z","timestamp":1669901022000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-022-00772-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1186\/s12969-022-00772-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.05.10.22274859","asserted-by":"object"}]},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"15 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants or their legal guardians gave written consent in participating in the study. The study was performed as a retrospective cohort study according to the principles of the Declaration of Helsinki and was approved by the local ethics committee at the University Hospital Motol (protocol No. EK 1412\/20).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}